Back to Newsroom

Biostage to Host Fiscal Year 2016 Update Conference Call

HOLLISTON, Mass., March 2, 2017 /PRNewswire/ — Biostage, Inc. (Nasdaq: BSTG), (“Biostage” or the “Company”), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, announced today that it will report its financial results for the year ended December 31, 2016 in a press release that will be issued pre-market on Thursday, March 9, 2017. Biostage Management also announced that it will host a conference call with live audio webcast that same day at 9:00 a.m. ET to review its operational progress, expected near-term milestones and financial report.

Click here to read the full release